Enduring Response to Everolimus as Third-Line Therapy in a Patient With Advanced Renal Cell Carcinoma, Including Small-Bowel Metastases: Loss of FHIT but Normal VHL Gene Status - Broom, R J; Caldwell, I; Hanning, F (Clin Genitourin Cancer, 2012)
et al.